FABP5 and triple-negative breast carcinoma: Curcumin suppresses the expression of FABP5 and PPARβ/δ, thereby overcoming the resistance to retinoic acid in MDA-MB-231 and MD-MB-468 cell lines (triple-negative breast cancer).